Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy

被引:40
作者
Velaphi, S
Siegel, JD
Wendel, GD
Cushion, N
Eid, WM
Sánchez, PJ
机构
[1] Univ Texas, Dept Pediat, SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Texas, Dept Obstet & Gynecol, SW Med Ctr Dallas, Dallas, TX 75390 USA
关键词
group B streptococcus; chemoprophylaxis; penicillin G; neonatal sepsis; ampicillin;
D O I
10.1542/peds.111.3.541
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. In January 1995, a combined maternal and neonatal protocol for prevention of early-onset group B streptococcal (GBS) infection was implemented that consisted of a risk factor-based approach for maternal intrapartum chemoprophylaxis using ampicillin combined with a single intramuscular dose of penicillin given to all newborns within 1 hour of delivery. The objective of this study was to review the cases of early-onset GBS infections that occurred from 1995 to 1999 to identify factors associated with their continued occurrence despite implementation of a GBS chemoprophylaxis protocol. Methods. Infants less than or equal to72 hours of age with early-onset GBS infection born at Parkland Memorial Hospital in Dallas from January 1995 to December 1999 were identified through a prospective laboratory-based surveillance system. Maternal and infant medical records were reviewed for clinical and demographic data. Results. There were 32 cases (0.47/1000 live births) of early-onset GBS infection for the 5-year period. This represented a 76% reduction compared with the rate from 1986 to 1994 (1.95/1000), when there was no protocol for GBS chemoprophylaxis. Thirteen cases (41%) did not have any identifiable maternal risk factor. Of the 19 cases (59%) with risk factors, maternal intrapartum fever was the most frequent (15 [79%]), followed by prematurity (6 [32%]) and prolonged rupture of membranes (6 [32%]). Among the 19 mothers with risk factors, 15 (79%) mothers received intrapartum chemoprophylaxis, and 12 (80%) of the 15 mothers had intrapartum fever. Only 33% of mothers with risk factors received greater than or equal to2 doses of intrapartum chemoprophylaxis, and among those with intrapartum fever, 25% received greater than or equal to2 doses. None of the 32 infants with early-onset GBS infection received the combination of intrapartum ampicillin and postnatal penicillin. Conclusions. A combined obstetric and neonatal chemoprophylaxis protocol significantly reduced early-onset GBS infection. Maternal intrapartum fever was the most frequent risk factor associated with failure of chemoprophylaxis.
引用
收藏
页码:541 / 547
页数:7
相关论文
共 30 条
[1]  
[Anonymous], INFECT DIS FETUS NEW
[2]  
Ascher D P, 1993, J Perinatol, V13, P212
[3]   Early-onset neonatal sepsis in the era of group B streptococcal prevention [J].
Baltimore, RS ;
Huie, SM ;
Meek, JI ;
Schuchat, A ;
O'Brien, KL .
PEDIATRICS, 2001, 108 (05) :1094-1098
[4]   PREVENTION OF EARLY-ONSET NEONATAL GROUP-B STREPTOCOCCAL DISEASE WITH SELECTIVE INTRAPARTUM CHEMOPROPHYLAXIS [J].
BOYER, KM ;
GOTOFF, SP .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (26) :1665-1669
[5]   SELECTIVE INTRAPARTUM CHEMOPROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL EARLY-ONSET DISEASE .1. EPIDEMIOLOGIC RATIONALE [J].
BOYER, KM ;
GADZALA, CA ;
BURD, LI ;
FISHER, DE ;
PATON, JB ;
GOTOFF, SP .
JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (05) :795-801
[6]   The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants [J].
Bromberger, P ;
Lawrence, JM ;
Braun, D ;
Saunders, B ;
Contreras, R ;
Petitti, DB .
PEDIATRICS, 2000, 106 (02) :244-250
[7]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1
[8]   Impact of a risk-based prevention policy on neonatal group B streptococcal disease [J].
Factor, SH ;
Levine, OS ;
Nassar, A ;
Potter, J ;
Fajardo, A ;
O'Sullivan, MJ ;
Schuchat, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (06) :1568-1571
[9]   GROUP-B STREPTOCOCCUS (GBS) AND NEONATAL INFECTIONS - THE CASE FOR INTRAPARTUM CHEMOPROPHYLAXIS [J].
GARLAND, SM ;
FLIEGNER, JR .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1991, 31 (02) :119-122
[10]  
GIBBS RS, 1994, OBSTET GYNECOL, V84, P496